Formulation and Characterization of Drug Loaded Nonionic Surfactant Vesicles (Niosomes) for Oral Bioavailability Enhancement

Nonionic surfactant vesicles (niosomes) were formulated with an aim of enhancing the oral bioavailability of tenofovir disoproxil fumarate (TDF), an anti-HIV drug. Niosomes were formulated by conventional thin film hydration technique with different molar ratios of surfactant, cholesterol, and dicet...

Full description

Saved in:
Bibliographic Details
Main Authors: Sunil Kamboj, Vipin Saini, Suman Bala
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2014/959741
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849414636295684096
author Sunil Kamboj
Vipin Saini
Suman Bala
author_facet Sunil Kamboj
Vipin Saini
Suman Bala
author_sort Sunil Kamboj
collection DOAJ
description Nonionic surfactant vesicles (niosomes) were formulated with an aim of enhancing the oral bioavailability of tenofovir disoproxil fumarate (TDF), an anti-HIV drug. Niosomes were formulated by conventional thin film hydration technique with different molar ratios of surfactant, cholesterol, and dicetyl phosphate. The formulated niosomes were found spherical in shape, ranging from 2.95 μm to 10.91 μm in size. Vesicles with 1 : 1 : 0.1 ratios of surfactant : cholesterol : dicetyl phosphate with each grade of span were found to have higher entrapment efficiencies, which were further selected for in vitro and in vivo studies. Vesicles formulated with sorbitan monostearate were found to have maximum drug release (99.091%) at the end of 24 hours and followed zero order release kinetics. The results of in vivo study revealed that the niosomes significantly enhanced the oral bioavailability of TDF in rats after a dose of 95 mg/kg. The average relative bioavailability of niosomes in relation to plane drug solution was found to be 2.58, indicating more than twofold increase in oral bioavailability of TDF. Significant increase in mean residential time (MRT) was also found, reflecting release retarding efficacy of the vesicles. In conclusion, niosomes could be a promising delivery for TDF with improved oral bioavailability and prolonged release profiles.
format Article
id doaj-art-6bf31fdb9f794bb4a60d92aa21ce1bbe
institution Kabale University
issn 2356-6140
1537-744X
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-6bf31fdb9f794bb4a60d92aa21ce1bbe2025-08-20T03:33:46ZengWileyThe Scientific World Journal2356-61401537-744X2014-01-01201410.1155/2014/959741959741Formulation and Characterization of Drug Loaded Nonionic Surfactant Vesicles (Niosomes) for Oral Bioavailability EnhancementSunil Kamboj0Vipin Saini1Suman Bala2M.M. College of Pharmacy, Maharishi Markandeshwar University, Mullana, Ambala 133207, Haryana, IndiaM.M. College of Pharmacy, Maharishi Markandeshwar University, Mullana, Ambala 133207, Haryana, IndiaM.M. College of Pharmacy, Maharishi Markandeshwar University, Mullana, Ambala 133207, Haryana, IndiaNonionic surfactant vesicles (niosomes) were formulated with an aim of enhancing the oral bioavailability of tenofovir disoproxil fumarate (TDF), an anti-HIV drug. Niosomes were formulated by conventional thin film hydration technique with different molar ratios of surfactant, cholesterol, and dicetyl phosphate. The formulated niosomes were found spherical in shape, ranging from 2.95 μm to 10.91 μm in size. Vesicles with 1 : 1 : 0.1 ratios of surfactant : cholesterol : dicetyl phosphate with each grade of span were found to have higher entrapment efficiencies, which were further selected for in vitro and in vivo studies. Vesicles formulated with sorbitan monostearate were found to have maximum drug release (99.091%) at the end of 24 hours and followed zero order release kinetics. The results of in vivo study revealed that the niosomes significantly enhanced the oral bioavailability of TDF in rats after a dose of 95 mg/kg. The average relative bioavailability of niosomes in relation to plane drug solution was found to be 2.58, indicating more than twofold increase in oral bioavailability of TDF. Significant increase in mean residential time (MRT) was also found, reflecting release retarding efficacy of the vesicles. In conclusion, niosomes could be a promising delivery for TDF with improved oral bioavailability and prolonged release profiles.http://dx.doi.org/10.1155/2014/959741
spellingShingle Sunil Kamboj
Vipin Saini
Suman Bala
Formulation and Characterization of Drug Loaded Nonionic Surfactant Vesicles (Niosomes) for Oral Bioavailability Enhancement
The Scientific World Journal
title Formulation and Characterization of Drug Loaded Nonionic Surfactant Vesicles (Niosomes) for Oral Bioavailability Enhancement
title_full Formulation and Characterization of Drug Loaded Nonionic Surfactant Vesicles (Niosomes) for Oral Bioavailability Enhancement
title_fullStr Formulation and Characterization of Drug Loaded Nonionic Surfactant Vesicles (Niosomes) for Oral Bioavailability Enhancement
title_full_unstemmed Formulation and Characterization of Drug Loaded Nonionic Surfactant Vesicles (Niosomes) for Oral Bioavailability Enhancement
title_short Formulation and Characterization of Drug Loaded Nonionic Surfactant Vesicles (Niosomes) for Oral Bioavailability Enhancement
title_sort formulation and characterization of drug loaded nonionic surfactant vesicles niosomes for oral bioavailability enhancement
url http://dx.doi.org/10.1155/2014/959741
work_keys_str_mv AT sunilkamboj formulationandcharacterizationofdrugloadednonionicsurfactantvesiclesniosomesfororalbioavailabilityenhancement
AT vipinsaini formulationandcharacterizationofdrugloadednonionicsurfactantvesiclesniosomesfororalbioavailabilityenhancement
AT sumanbala formulationandcharacterizationofdrugloadednonionicsurfactantvesiclesniosomesfororalbioavailabilityenhancement